Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
72.76
0.00 (0.00%)
Aug 5, 2026, 3:31 PM EDT - Market open
Nektar Therapeutics Employees
Nektar Therapeutics had 63 employees as of December 31, 2025. The number of employees increased by 2 or 3.28% compared to the previous year.
Employees
63
Change (1Y)
2
Growth (1Y)
3.28%
Revenue / Employee
$883,063
Profits / Employee
-$2,509,492
Market Cap
2.46B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 63 | 2 | 3.28% |
| Dec 31, 2024 | 61 | -76 | -55.47% |
| Dec 31, 2023 | 137 | -79 | -36.57% |
| Dec 31, 2022 | 216 | -524 | -70.81% |
| Dec 31, 2021 | 740 | 22 | 3.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Vericel | 398 |
| Vera Therapeutics | 339 |
| Nurix Therapeutics | 317 |
| Precigen | 160 |
| Pharvaris | 134 |
| Kodiak Sciences | 130 |
| Mineralys Therapeutics | 76 |
NKTR News
- 7 days ago - Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets - PRNewsWire
- 11 days ago - Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 14 days ago - Nektar initiated with a Buy at Canaccord on rezpegaldesleukin potential - TheFly
- 14 days ago - Nektar initiated with a Buy at Canaccord - TheFly
- 15 days ago - Nektar begins Phase 3 program of rezpegaldesleukin in atopic dermatitis - TheFly
- 15 days ago - Nektar Therapeutics Announces Start of Phase 3 ZENITH AD Program Evaluating Novel Regulatory T-Cell Biologic Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis - PRNewsWire
- 2 months ago - Nektar Therapeutics Transcript: AGM 2026 - Transcripts
- 2 months ago - Nektar Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts